NCT01140880View on ClinicalTrials.gov

Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men

PHASE2CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
HIV SeroconversionStimulant Abuse
Interventions
DRUG

Truvada

Truvada At qualifying exposure, participants will take 28 days' worth (at one pill per day) of 200 mg emtricitabine and 300 mg tenofovir DF (Truvada).

Trial Locations (1)

90028

Friends Community Center, A Division of Friends Research Institute, Inc., Los Angeles

Sponsors
All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

Friends Research Institute, Inc.

OTHER